Nature Communications (May 2018)

Integrated molecular subtyping defines a curable oligometastatic state in colorectal liver metastasis

  • Sean P. Pitroda,
  • Nikolai N. Khodarev,
  • Lei Huang,
  • Abhineet Uppal,
  • Sean C. Wightman,
  • Sabha Ganai,
  • Nora Joseph,
  • Jason Pitt,
  • Miguel Brown,
  • Martin Forde,
  • Kathy Mangold,
  • Lai Xue,
  • Christopher Weber,
  • Jeremy P. Segal,
  • Sabah Kadri,
  • Melinda E. Stack,
  • Sajid Khan,
  • Philip Paty,
  • Karen Kaul,
  • Jorge Andrade,
  • Kevin P. White,
  • Mark Talamonti,
  • Mitchell C. Posner,
  • Samuel Hellman,
  • Ralph R. Weichselbaum

DOI
https://doi.org/10.1038/s41467-018-04278-6
Journal volume & issue
Vol. 9, no. 1
pp. 1 – 8

Abstract

Read online

The oligometastasis hypothesis suggests certain metastases are limited in extent and curable with focal therapies. Here they identify three integrated molecular subtypes of colorectal cancer liver metastasis, which complement clinical risk stratification to distinguish the subset of oligometastatic patients.